Indaptus Therapeutics Inc
About
Indaptus Therapeutics Inc (NASDAQ:INDP) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 29 2025
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
Nov 17 2025
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
Nov 12 2025
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Sep 4 2025
Indaptus Therapeutics Provides Clinical Update
Sep 2 2025
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference
Financials
Revenue
$0
Market Cap
$4.15 M
EPS
-21.58